Saint John’s Cancer Institute 2020 Year in Review
2020 was a challenging year with the coronavirus pandemic, but our team at Saint John’s Cancer Institute at Providence Saint…
Recognized As A High Performing Hospital for Procedures and Conditions
2020 – 2021 High Performing Hospital We are excited to announce the U.S. News and World Report recognized Providence Saint…
Making Advancements in Cancer Treatments
The Translational Neurosciences department at the Saint John’s Cancer Institute is committed to accelerate the development of novel therapies for…
First COVID-19 Patient Treated Under Emergency Use IND At Providence Saint John’s Health Center
Originally published: https://www.biospace.com/article/releases/first-covid-19-patient-treated-under-emergency-use-ind-at-providence-saint-john-s-health-center-using-stemedica-ischemia-tolerant-allogeneic-mesenchymal-bone-marrow-cells/ SANTA MONICA, Calif., April 20, 2020 /PRNewswire/ — A single patient, emergency Investigational New Drug (IND) use was cleared by…
How Steroids Can Impact the Bone Health of Brain Cancer Patients
Steroids have helped patients with brain cancer for decades. The powerful medications aid in reducing tumor-associated edema and brain swelling…